Times Square Capital Management, LLC Outset Medical, Inc. Transaction History

Times Square Capital Management, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$13.46 - $48.16 $4 Million - $14.3 Million	-297,500 Reduced 38.84%	468,380 $6.96 Million
Q1 2022 May 06, 2022	SELL	$34.22 - $47.24 $7.28 Million - $10.1 Million	-212,880 Reduced 21.75%	765,880 $34.8 Million
Q4 2021 Feb 04, 2022	SELL	$43.29 - $58.77 $1.55 Million - $2.1 Million	-35,800 Reduced 3.53%	978,760 $45.1 Million
Q3 2021 Nov 08, 2021	SELL	$36.86 - $54.98 $205,310 - $306,238	-5,570 Reduced 0.55%	1,014,560 $50.2 Million
Q2 2021 Aug 09, 2021	BUY	$41.49 - $59.92 $3.22 Million - $4.65 Million	77,570 Added 8.23%	1,020,130 $51 Million
Q1 2021 May 12, 2021	BUY	$46.94 - $58.66 $6.98 Million - $8.72 Million	148,645 Added 18.72%	942,560 $51.3 Million
Q4 2020 Feb 12, 2021	BUY	$42.51 - $64.0 $27.4 Million - $41.3 Million	645,615 Added 435.34%	793,915 $45.1 Million
Q3 2020 Nov 06, 2020	BUY	$49.75 - $60.68 $7.38 Million - $9 Million	148,300 New	148,300 $7.42 Million

131

39M

65.1K

91.3K

Ticker OM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 48,007,300
Market Cap $32.6M
Description
Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was ...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.